Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
- Scope and Methodology
- Market Analysis
- Trends and Considerations
CHAPTER TWO: PEPTIDES, PROTEINS, ENZYMES AND ANTIBODIES
- Peptides
- Tachykinin Peptides
- Vasoactive Intestinal Peptides
- Pancreatic Polypeptide-Related Peptides
- Opioid Peptides
- Calcitonin Peptides
- Other Peptides
- Proteins
- Enzymes
- Coenzymes
- Antibodies
- Allotype
CHAPTER THREE: CLINICAL APPLICATIONS OF APPLICATIONS OF PROTEIN-BASED THERAPEUTICS
- Advantages of Protein Therapeutics
- Group I: Enzymes and Regulatory Proteins
- Group II: Targeted Proteins
- Group III:
- Toward the Future
CHAPTER FOUR: MARKET ANALYSIS
- Growth Rate
- Forecast
- Trending By Product Class
- Vaccines Market Forecast
- Antithrobins Market Forecast
- Hematopoietics Market Forecast
- Insulin Market Forecast
- Growth Hormones Market Forecast
- Plasma Proteins Market Forecast
- Trending by Product Class
- Pipeline
CHAPTER FIVE: COMPANY SNAPSHOTS
- Agennix
- Altus Pharmaceuticals
- Amgen
- Amylin Pharmaceuticals
- Biogen IDEC
- BioMarin Pharmaceutical, Inc.
- Cell Genesys, Inc
- Eli Lilly & Company
- Genentech, Inc.
- Genzyme Corporation
- Human Genome Sciences
- Medarex
- Neose Technologies, Inc.
- Novo Nordisk, Inc (USA)
- Regeneron Pharmaceuticals, Inc.
- Xoma, Ltd.
CHAPTER SIX: CONCLUSIONS AND STRATEGIC IMPLICATIONS
- First Conclusion
- Second Conclusion
- Third Conclusion
- Fourth Conclusion
- Fifth Conclusion
- Sixth Conclusion
- Seventh Conclusion
- Eighth Conclusion
- Ninth Conclusion
- Tenth Conclusion
APPENDIX A: GLOSSARY
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Estimated Global Market for Protein-Based Therapeutics by Major
Product Class: 2008 - 2018
- Figure 1-1: Trending in the Global Market for Protein-Based Therapeutics:
2008 - 2018
- Figure 1-2: Trending in the Protein-Based Therapeutics Global Market by
Product Class: 2008 - 2018
CHAPTER TWO: PEPTIDES, PROTEINS, ENZYMES AND ANTIBODIES
- Table 2-1: The Naturally Occurring Amino Acids
- Table 2-2: Significant Peptides in Biological Functions
- Table 2-3: Key Features of Immunoglobulin Isotypes
- Table 2-4: Immunoglobulin Functional Properties
CHAPTER THREE: CLINICAL APPLICATIONS OF APPLICATIONS OF PROTEIN-BASED THERAPEUTICS
- Table 3-1: Replacement Protein Therapeutics: Subgroup Ia
- Table 3-2: Augmenting Protein Therapeutics: Subgroup Ib
- Table 3-3: Protein Therapeutics with a Novel Function Activity: Subgroup Ic
- Table 3-4: Protein Vaccines: Subgroup IIa
- Table 3-5: Drug Delivery Protein Therapeutics: Subgroup IIb
- Table 3-6: Protein Vaccines: Group III
- Figure 3-1: Biotechnology-Based Therapeutics in Development by Product
Category: 2008 (Growth Factors, Interferons, Interleukins, Monoclonal
Antibodies (mAbs), Recombinant Hormones/Proteins, Vaccines, Others)
- Figure 3-2: Biotechnology-Based Therapeutics in Development by Protein and
Non-Protein Category: 2008
- Figure 3-3: Biotechnology-Based Therapeutics in Development by Clinical
Application (Disease State): 2008
- Table 3-7: Protein-Based Therapeutics in Development: 2008
- Figure 3-4: Distribution of Protein-Based Therapeutics in Development by
Orphan and Non-Orphan Drug Categories: 2008
- Figure 3-5: Distribution of Protein-Based Therapeutics in Development
Type: 2008
- Figure 3-6: Distribution of Protein-Based Vaccines in Development by
Recombinant and Non-Recombinant Categories: 2008
CHAPTER FOUR: MARKET ANALYSIS
- Table 4-1: Estimated Global Market for Protein-Based Therapeutics by Major
Product Class: 2008 - 2018
- Figure 4-1 : Trending in the Global Market for Protein-Based Therapeutics:
2008 - 2018
- Figure 4-2: Trending in the Protein-Based Therapeutics Global Market by
Product Class: 2008 - 2018
- Figure 4-3: Trending in the Protein-Based Therapeutics Global Market by
Product Class: 2008 - 2018
- Figure 4-4: Biopharmaceutical Approvals by the United States FDA: 1988 -
2007
- Table 4-2: Biopharmaceuticals Approved by the FDA: 2006 - 2008
- Table 4-3: Global Markets for Cytokines, Vaccines and Hematopoietic
Factors: 2008 - 2018
- Table 4-4: Companies Engaged in Protein-Based Therapeutics Development
|
Related Report
|
View Cart
